-
CDMO Ology Bioservices Wins $8.4m DoD Award
contractpharma
August 21, 2018
a biologics contract development and manufacturing organization (CDMO), was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS......
-
Cambrex enters growing finished dosage form market
cphi-online
July 26, 2018
Acquisition of Halo Pharma adds competencies including developing and manufacturing products for pediatric indications.
-
Oncobiologics Enters First CDMO Contract
contractpharma
June 19, 2018
Oncobiologics? has entered into a Master Services Agreement (MSA) with?Sonnet BioTherapeutics, a privately held development stage biopharmaceutical company, and has officially launched its BioSymphony Platform-based contract development and manufacturing
-
WuXi Biologics to build new CDMO plant
biospectrumasia
May 18, 2018
WuXi Biologics is planning to build an integrated biologics development, clinical and commercial manufacturing centre in the city of Shijiazhuang, capital of Hebei province in northern China.
-
Ardena acquisition strengthens API offering
cphi-online
May 10, 2018
CDMO Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients
-
Sterling Pharma Invests ￡6M To Expand Offerings
contractpharma
April 23, 2018
For its pilot plant facility to enhance scale-up and small to midscale commercial API manufacturing capabilities
-
CMAB Biopharma raises funds worth $34 M
biospectrumasia
April 03, 2018
The funding proceeds will be used to upgrade CMAB’s 2,000L Good Manufacturing Practices (GMP) facilities.
-
Nanologica and Sterling partnership furthers new business venture
cphi-online
March 19, 2018
Partnership enables production volumes of NLAB Saga chromatography material to increase from tens of kilograms to tens of tonnes.
-
Hovione divestment marks its commitment to supplying highly specialized APIs
cphi-online
March 12, 2018
Portuguese company exits the large volume business of contrast media to concentrate on its CDMO business.
-
ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology
contractpharma
February 08, 2018
Research License Agreement on Unique Technology to Assess Drug Effects on the Immune System in Vitro
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
